Associations between HLA types and serum antibodies to native and denatured type II collagen were sought in 105 patients with rheumatoid arthritis (RA). Antibodies were measured using a solid phase radioimmunoassay. There were no significant associations between any HLA antigens (A, B, or DR) and a high antibody titre to native collagen. There were significant associations, however, between HLA antigens and high antibody titres to denatured collagen. Although DR4 did not show an association, the phenotype A2+DR4+ did; this was not related to A2 as A2+DR-was not associated with a high antibody titre. No single B locus antigen showed an association, but several B locus antigens, B12, B15, and B40, were included in phenotypes with A2 and DR4 which were associated with a high antibody titre to denatured collagen. These HLA associations with anticollagen type H are best explained by a gene other than DR4 (but in linkage with it) which may regulate the antibody response to denatured collagen. If so, this would represent an HLA gene in addition to DR4 that is active in RA.
Rheumatoid arthritis (RA) is a disease with strong immunogenetic associations. Although the primary HLA association found in RA has been with DR4,' the distribution of other class I and class II HLA alleles is changed, and certain extended haplotypes ('supratypes') ofDR4 occur more commonly than in a healthy population.2 3 Moreover, clinical studies have shown associations between HLA alleles and particular patterns of disease.A In the study by Jaraquemada et al the prevalence of A2, Cw3, Bw62, Dw4, and DR4 was greater in patients with extraarticular disease, including digital or cutaneous vasculitis, fibrosing alveolitis, and neuropathy, and the prevalence of DR4, Dw4, and A2 was higher in patients with subcutaneous nodules. 4 We previously studied 40 HLA typed patients with severe RA, many of whom had vasculitis, and showed that antibody titres to denatured collagen were significantly higher in the serum of those who were DR4 positive than in those who were DR4 negative; antibody titres were also non-significantly associated with those HLA haplotypes which are more prevalent in RA. 13 This study was designed to achieve the following: (a) extend our previous work on the association between antibodies to collagen and HLA types; (b) include patients with less severe disease; (c) examine associations between collagen antibodies and particular combinations of HLA types which are likely to measured as counts per minute (cpm) of radioactivity bound in the radioimmunoassay at a 1/100 dilution to serum. For convenience the cpm for each assay was taken to specify the titre of anticollagen antibody, and results were expressed as mhean cpm (SD). As antibody titres within the group with RA were not normally distributed, however, statistical analysis was carried out by the two tailed nonparametric Mann-Whitne'y U test. Differences were regarded as non-significant if the probability that they arose by chance was greater than 0-05. As there was an a priori reason for the analyses, no correction was applied for multiple comparisons.
Results
The mean antibody titre (1 SD) to native collagen in the 50 healthy controls was 426 (258) cpm and the mean antibody titre in the patients with RA was 1110 (1820) (p<0001). No significant associations between any HLA haplotypes and a high antibody titre to native collagen were evident (data not shown).
The mean antibody titre to denatured collagen for the 50 healthy controls was 1860 (874) cpm and that for the patients with RA was 4200 (4520) cpm (p<0 001). 
